Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Liraglutide for Sale > 99% Purity Weight Loss Liraglutide 204756-20-2 best price
99% Purity Weight Loss Liraglutide 204756-20-2 best price buy - large image1
99% Purity Weight Loss Liraglutide 204756-20-2 best price buy - image1
99% Purity Weight Loss Liraglutide 204756-20-2 best price buy - image2
99% Purity Weight Loss Liraglutide 204756-20-2 best price buy - image3
99% Purity Weight Loss Liraglutide 204756-20-2 best price buy - image4
99% Purity Weight Loss Liraglutide 204756-20-2 best price buy - image5
99% Purity Weight Loss Liraglutide 204756-20-2 best price buy - image6

99% Purity Weight Loss Liraglutide 204756-20-2 best price

TDS 24 Inquiries

Unit Price: Get Latest Price
CAS No.:

204656-20-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

tianjin

Brand:

Yueqi

Packaging:

10mg/vial

Sample Available:

Yes

Price valid (until):

2024-02-09

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
3 days
Qualification:
Main Products:

retatrutide,Semaglutide,tirzepatide,BPC-157,NAD,glutathione

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide 10mg per vial..


      Product Detail  


    Function and Usage of Liraglutide 204656-20-2

    1、 Type 2 diabetes
    Liraglutide improves control of blood glucose.It reduces meal-related hyperglycemia

    (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing

    glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion.
    In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over

    more traditional therapies for type 2 diabetes:

    ·  Liraglutide acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only

    when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows

    negligible risk of hypoglycemia.

    ·  Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells

    (seen in animal studies).

    ·  Liraglutide decreases appetite and inhibits body weight gain, as shown in a head-to-head study

    versus glimepiride.

    ·  Liraglutide lowers blood triglyceride levels.


    2、Obesity
    Liraglutide has been approved as an injectable adjunct to a reduced-calorie diet and increased

    physical activity for chronic weight management in adult patients. The specified criteria are an

    initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater

    (overweight), in the presence of at least one weight-related comorbid condition

    (e.g.hypertension, type 2 diabetes mellitus, or dyslipidemia). In late 2014, data were reported from

    the SCALE™ Obesity and Prediabetes trial, which is a randomised, double-blind, placebo-controlled,

    multinational trial in non-diabetic people with obesity and non-diabetic people who are overweight

    with comorbidities. In this phase 3a trial, there were 3,731 participants randomised to treatment

    with liraglutide 3 mg or placebo, both in combination with diet and exercise. Those who completed

    the 56-week trial achieved an average weight loss of 9.2%, to be compared with a 3.5% reduction in

    the placebo group.

    Items Specifications
    Name   Liraglutide 204756-20-2
    Purity 99%
    Grade Pharmaceutical grade

    Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide 10mg per vial-Detailed Image 1Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide 10mg per vial-Detailed Image 2Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide 10mg per vial-Detailed Image 3Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide 10mg per vial-Detailed Image 4Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide 10mg per vial-Detailed Image 5

    Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide 10mg per vial-Detailed Image 6Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide 10mg per vial-Detailed Image 7

    How is Retatrutide different from Semaglutide and Trizepatide ?

    Mechanism:

    1. Semaglutide work as (GLP-1) hormone agonist.

    2. Tirezepatide work as (GLP-1 & GIP ) hormone agonist.

    3. Retatrutide work as (GLP-1 & GIP & Glucagon) hormones agonist.


    Weight loss in trials:

    1. Semaglutide led to a 6-12% reduction in body weight in 28 weeks

    2. Tirezepatide led to a 15-20% reduction in body weight in 72 weeks

    3. Retatrutide led to a 25% reduction in body weight in 48 weeks

    Why choose us?

    ​1. Higher quality products (>=99% purity) for most of peptides and raws. Quality Guaranteed: Many HPLC test reports are available (Janoshik).

    2. Domestic warehouses and fast delivery.

    3. Ship worldwide with safe and secure lines: 100% delivery guaranteed. No worry about Customs issues.

    4. Special Service: Drop-shipping if need.

    5. Cheapest prices in the market, unbeatable!

    6. Many payment options: Paypal, bank transfer, alipay, wechat, bitcoin, USDT. 

    put...

    Shop 99% Purity Weight Loss Liraglutide 204756-20-2 best price-Detailed Image 8
    Shop 99% Purity Weight Loss Liraglutide 204756-20-2 best price-Detailed Image 9
    ECHEMI Editorial Reference
    Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
    Liraglutide is characterized as a white to almost white powder. It is freely soluble in aqueous base solutions (> 270 mg/mL), but its water solubility decreases below pH 7 and reaches its lowest level at pH 4-5 (approximately 0.05 mg/mL). Solubility increases marginally at pH 2.5 where it is very slightly soluble (≤ 0.8 mg/mL). Liraglutide is soluble in methanol (68 mg/mL) and very slightly soluble in ethanol (1.1 mg/mL). The isoelectric point of liraglutide is approximately 4.9. The pH of a 1 mg/mL aqueous solution of drug substance is approximately 9.3.
    ChEBI: Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.
    Liraglutide is GLP-1(1–37) modified at Ly: the -amino group is acylated with an (N-hexadecanoyl)glutam- -yl moiety that noncovalently but avidly binds tohuman serum albumin. (Also, Lys is conservatively replacedwith Arg.) These changes provide for a greatly extendedserum t12 of~10 to 15 hours after sc administration(0.6–1.8 mg), allowing for once-daily dosing.Liraglutide (Victoza, Novo Nordisk) is awaiting approvalby the FDA, EMEA, and the Koˉ roˉ -shoˉ (Japan).
    Liraglutide peptide is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 3751 Dalton and a Molecular formula of C172H265N43O51.

    Certificates
    • 99% Purity Weight Loss Liraglutide 204756-20-2 best price Certificates 1 TDS

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Research
    Class:

    GLP-1 receptor agonist (acylated GLP-1 analog, 31-amino-acid peptide)

    Status:

    FDA-approved (Victoza 2010, Saxenda 2014 for obesity)

    Mechanism:

    A 31-amino-acid GLP-1 analog with a C16 fatty-acid chain (palmitoyl) attached to Lys26 via a gamma-glutamic acid spacer. This fatty-acid modification enables reversible binding to serum albumin, extending the half-life to ~13 hours. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.

    EC50 (GLP1R Ec50):

    ~10 nM

    Source:

    DrugBank: DB06655; Knudsen LB, et al. J Med Chem. 2000;43(9):1664-1669.DOI

    Clinical Development:

    NCT00781922; NCT01272219

    FDA:

    Victoza, Saxenda (approved 2010-01-25)

    References
    ChEMBL:

    CHEMBL1213363

    DrugBank:

    DB06655

    KEGG DRUG:

    D09199

    PubChem:

    PubChem

    Disclaimer:

    Liraglutide is FDA-approved as a prescription medicine (Victoza for T2DM, Saxenda for obesity). This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    retatrutide,Semaglutide,tirzepatide,BPC-157,NAD,glutathione

    Location:

    Erqi District, Zhengzhou City

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2023

    Supplying 99%+ high quality chemical products

    More than 1,000 quality products|10 production lines|Provide OEM services

    Founded in 2015
    Founded in 2015, Zhengzhou Yueqi New Materials Co., Ltd is located in Zhengzhou, Henan Province. As one of the most dynamic factories and foreign trade companies in the Chinese market, we have a registered capital of RMB 3 million. 

    Our Benefits from Our Advantages
    We can provide fast delivery. The average lead time during the peak season is within 15 workdays, and in the off season is one month. We have successfully shipped many chemical raw materials to many countries around the world. Good feedbacks and repeat orders support the development of our company. 

    Independent Production Lines
    We have 10 production lines for pharmaceutical intermediates, organic solvents and other raw materials. In addition, we have an API production workshop with independent research and development production lines, as well as an API research and development test center. We can provide OEM services and accept small orders.

  • Inquiry History
    24 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    South Korea

    Liraglutide

    1 G Sep 19, 2026
    United Kingdom

    Liraglutide

    20 MG Jul 8, 2026
    United States

    MIC

    2 MT May 20, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    United States

    liraglutide

    1 MT Nov 22, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    1  Jan 21, 2026
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    Israel

    Liraglutide

    1 G Aug 26, 2024
    India

    Liraglutide

    10 G Jun 26, 2024
    India

    Liraglutide

    100 G Mar 4, 2024
    United States

    Semaglutide Liraglutide powder

    10 G Feb 20, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.